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Musculoskeletal pain is associated with altered motor control that despite short-term benefit, 
is hypothesised to have long-term consequences, contributing to the development of chronic 
pain. However, data on how motor control is altered when pain is sustained beyond a 
transient event are scarce. Here, we investigated motor adaptation, and its relationship to 
corticomotor excitability, in the transition to sustained muscle pain. Twenty-eight healthy 
individuals were injected with nerve growth factor (NGF) into the right extensor carpi 
radialis brevis (ECRB) muscle on Days 0 and 2. Motor adaptation and corticomotor 
excitability were assessed on Day -2, prior to injection on Days 0 and 2, and again on Days 4 
and 14. Motor adaptation was quantified during a radial-ulnar movement as kinematic 
variability of wrist flexion-extension and pronation-supination, and as electromyographic 
(EMG) variability of ECRB activity. Pain, muscle soreness, and functional limitation were 
assessed from Days 0-14. Pain, muscle soreness and functional limitation were evident at 
Days 2 and 4 (p<0.001). EMG variability reduced at D ys 4 and 14 (p<0.04), with no change 
in kinematic variability (p=0.9). However, data revealed variation in EMG and kinematic 
variability between individuals: some displayed increased motor variability while others a 
decrease. Individuals who displayed an increase in EMG variability following four days of 
pain also displayed an increase in corticomotor excitability (r=0.43, p=0.034). These findings 
suggest individual adaptation of the motor system in the transition to sustained pain that 
could have implications for clinical musculoskeleta p in disorders. 
 
Keywords: Motor cortex plasticity, Musculoskeletal pain, Transcranial magnetic stimulation, 











Musculoskeletal pain is associated with adaptations n motor control [2,34,60]. In the 
short-term, altered motor control (or motor adaptation) is considered a beneficial response 
serving to protect the body from further pain or injury [35]. However, in the long-term, 
altered motor control is hypothesised to contribute to the maintenance or recurrence of pain 
[35,47,61]. Although numerous cross-sectional studies have documented motor adaptation in 
acute and chronic pain [32,36,44,91,94], few studies have characterised motor adaptation in 
the transition to sustained pain. Understanding motor adaptation, and the underlying 
mechanisms, as pain develops may have implications for understanding why some people fail 
to recover from musculoskeletal pain. 
 
A spectrum of motor control changes have been documented in people with acute and 
chronic pain ranging from subtle changes in muscle activity to complete movement 
avoidance [35,34]. Although there is evidence of individual-specific motor adaptation 
[33,78,87], the most consistent finding in response to acute experimental pain (lasting 7-15 
minutes) is an increase in motor variability (i.e. greater variation in muscle activation, motion 
of joints and force applied during an isometric contraction [32,45,48,79]). However, in 
studies of people with chronic neck, shoulder, back, and knee pain, decreased motor 
variability has been observed [22,28,31,44,48,55]. One interpretation is that an increase in 
motor variability during acute pain reflects the search for a motor strategy that maximises 
task performance while minimising pain, while in chronic pain, reduced variability reflects an 
avoidance strategy that limits painful movements and postures [6,57,79]. However, in the 
long-term, reduced variation in motor output is thought to increase accumulative load on 
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variability in the acute and chronic stages of pain suggest motor adaptation varies as a 
function of pain duration. 
 
Only one study has examined motor adaptation as pain progressively develops and is 
sustained over time [53]. Compared to controls, force direction, but not force variation, was 
greater during an isometric wrist-extension contraction when pain lasted up to four days. 
However, variability in muscle activation and movement kinematics were not explored. 
Further, no study has investigated the relationship between motor adaptation and 
corticomotor excitability in the transition to sustained pain despite evidence for a relationship 
in cross-sectional studies. For example, in chronic ba k pain, a posterior and lateral shift and 
an increase in excitability of the corticomotor representation of the transverse abdominis 
muscle was associated with a delay in activation of this muscle during arm movement [85].  
 
Here, we used repeated intramuscular injection of nerve growth factor to induce 
muscle pain that progressively developed over 4 days in order to investigate i) the nature and 
time-course of motor adaptation (variability in muscle activation and movement kinematics) 
and ii) the relationship between motor adaptation and corticomotor excitability, in the 
transition to sustained muscle pain. Based on previous studies [72,79], it was hypothesised 
that motor variability would increase when pain was sustained for four days, and that the 















Twenty-eight healthy individuals (mean ± standard deviation [SD] age 23 ± 4 years; 
13 females) participated. All participants were right handed, verified by the Edinburgh 
Handedness Inventory [62]. Participants had no history of neurological or upper limb 
conditions and completed a transcranial magnetic stimulation (TMS) safety screen prior to 
study commencement [39]. All participants provided written, informed consent in accordance 
with the Declaration of Helsinki. The institutional Human Research Ethics Committee 
approved the study (H11949). Secondary outcomes from this protocol are published 
elsewhere and include the effects of NGF-induced pain on joint position sense [80]. 
 
An a priori sample size calculation was performed for the prima y aim using 
GLIMMPSE software [43] with data from a previous NGF and transcranial magnetic 
stimulation (TMS) study [72]. These data demonstrate a mean (SD) change in map volume of 
2 (1.2) mV at Day 4 following two NGF injections. Using these values, 25 subjects were 
needed to identify a minimum change in map volume of 2 (1.2) mV at Day 4 with a power of 
80% at the 0.05 significance level.  
 
Experimental protocol 
Each participant attended the laboratory on five occasions: Day -2, 0, 2, 4, and 14 
(Figure 1). As this study was focussed on motor adaption as pain developed and peaked 
(Days 0-4), rather than recovered (Days 5-14), testintervals providing higher temporal 
resolution in the early stage of the model were selct d. Indeed, studies have shown that pain 
progressively develops and peaks at Day 4 following 2 injections of NGF before gradually 
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acute symptoms, with pain and soreness first beginning to develop 3-hours post-injection 
[1,30,59,82]. For this reason, we did not include an outcome assessment timepoint 
immediately following NGF injection. 
 
On Days 0 and 2, nerve growth factor (NGF) was injected into the muscle belly of the 
right extensor carpi radialis brevis (ECRB) muscle. At the beginning of each session, maps of 
the corticomotor representation of the right ECRB muscle were obtained using transcranial 
magnetic stimulation (TMS). Pain intensity (numerical rating scale, NRS), muscle soreness 
(Likert scale), and functional limitation (patient rated tennis elbow evaluation, PRTEE) were 
recorded on Days 0, 2, 4, and 14. To examine motor variability, wrist angle kinematics and 
electromyographic data of the ECRB muscle during a wrist radial/ulnar deviation task were 
measured at each test session (Days -2, 0, 2, 4, and 14). The Day -2 (two days before Day 0) 
test session was included to assess the test-retest liability of performance on the radial/ulnar 
deviation task and corticomotor outcomes in the absence of pain (Day -2 versus Day 0).  
 
NGF-induced muscle pain  
Sterile recombinant human NGF (5 µg, 0.2 ml) was injected into the muscle belly of 
the right ECRB muscle using a 1-mL syringe with a disposable needle (27G) [30,72]. The 
site of injection was determined by identifying the position 1 cm lateral to a point 5 cm distal 
to the lateral epicondyle [7]. Palpation of the muscle belly of ECRB during resisted wrist 
extension and radial deviation confirmed the injection site. A mark was drawn around the 
injection site with a permanent marker to ensure consistent placement of the injection in the 
ECRB muscle across sessions. Injection of NGF at this site has been shown to induce 
sustained lateral elbow pain [7,19,72], with the experience of pain and soreness similar to that 
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Assessment of pain, muscle soreness, and functional limitation  
An 11-point numerical rating scale (NRS) (0 = no pain; 10 = worst pain imaginable) 
was used to assess pain intensity. Muscle soreness wa  assessed using a modified 7-point 
Likert scale: “0 = complete absence of soreness; 1 = light soreness in the muscle felt only 
when touched/vague ache; 2 = moderate soreness felt only when touched/a slight persistent 
ache; 3 = light muscle soreness when lifting or carying objects; 4 = light muscle soreness, 
stiffness or weakness when moving the wrist without gripping an object; 5 = moderate 
muscle soreness, stiffness or weakness when moving the wrist; and 6 = severe muscle 
soreness, stiffness or weakness that limits the ability to move” [30,77].   
 
The Patient-rated tennis elbow evaluation (PRTEE) was used to assess average pain 
and functional limitation. Scores for pain (5 items) and function (10 items) were combined to 
provide a total score ranging from 0 (no pain and no functional limitation) to 100 (worst pain 
imaginable with significant functional limitation) [46]. The PRTEE has excellent test-retest 
reliability (r = 0.77 – 0.93) and correlates well with the Disabilities of Arm, Shoulder, and 
Hand (DASH) Questionnaire in a persistent elbow pain opulation (r = 0.75) [69].  
 
Experimental set-up for assessment of motor variability  
An adapted version of the wrist radial/ulnar deviation task developed by Bergin et al. 
[6] was used to measure motor variability. This task was selected for two reasons. First, it 
was anticipated that changes in the excitability of c rticomotor projections to ECRB, as a 
result of NGF-induced pain, would relate to movements at the wrist that involve the primary 
action of ECRB (i.e. radial deviation) [6]. Second, this task has been demonstrated to 
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provides an established model to study the relationship between sustained forearm extensor 
pain, motor variability, and corticomotor excitability.    
 
To assess the kinematics of the right (injected) arm during the radial/ulnar deviation 
task, a two-segment model was used to 3D model the rig t forearm and hand [68]. Six active 
markers were positioned over the segments: 1) three refl ctive markers attached to the 
dorsum of the right hand between the head of the second and fifth metacarpal bones, and 2) 
three reflective markers attached to the dorsum of the forearm 2 cm proximal to the radial 
styloid (Figure 2A). Six virtual markers were digitsed to identify the medial and lateral 
epicondyle, ulna and radial styloid, and head of the second and fifth metacarpal bones. These 
virtual markers were used to create the 3D model of the forearm (medial and lateral 
epicondyle, ulna and radial styloid) and hand (ulna a d radial styloid, head of the second and 
fifth metacarpal bones). Based on the 3D model, joint angles for wrist radial-ulnar deviation, 
forearm pronation-supination, and wrist flexion-extension were calculated [26]. Movements 
of the clusters were recorded at 200 Hz by one position sensor containing three cameras 
(Optotrak Certus System, Northern Digital Inc., Waterloo, Canada) and processed using 
Visual 3D (C-Motion, Version 4, Germantown, MD).  
 
To assess muscle activation of ECRB during the radial/ulnar deviation task, surface 
EMG recordings were collected using a bipolar silver/silver chloride surface electrode 
positioned over the muscle belly. Prior to application, the skin was lightly abraded using 
Nuprep skin prep gel (Weaver and Company, Colorado, USA), then cleaned with alcohol.   
The EMG signals were band-pass filtered (20–450 Hz) and sampled at 1000 Hz (Zerowire 
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Participants were seated in an upright position with the right forearm resting on a 
horizontal platform in mid-position between pronation and supination with the elbow in 
approximately 90° flexion. The forearm was stabilized using an adjustable brace at the 
forearm and an adjustable clamp proximal to the wrist (Figure 2A). This ensured that 
participants started in the same position across experimental sessions, allowed unconstrained 
wrist motion and forearm rotation, and prevented upper limb movements from affecting 
performance during the radial/ulnar deviation task. The apparatus (Figure 2A) was fixed to a 
table, and the table was secured with a chair to the floor to ensure seat position was 
controlled over each experimental session.    
 
In the first experimental session (Day -2), the neutral position of the wrist, and 
maximal range of motion for radial and ulnar deviation were recorded. The neutral position 
was measured using a handheld goniometer, while maximal radial and ulnar range of motion 
were recorded using a laser pointer and a paper board. A small foam block with two laser 
pointers were attached to the hand of each participant (Figure 2A). Once the neutral position 
of the wrist was set, a blank paper board was placed 60 cm in front of the hand and the 
position of the active laser on the paper board wasm rked corresponding to the ‘neutral 
position’. To identify maximal radial and ulnar range of motion, the position of the active 
laser on the paper board was marked in maximal radial nd ulnar deviation. In addition to the 
active laser, the position of the reference laser was marked and used to ensure consistent 
orientation of the hand in the neutral position befor  commencing the task (Figure 2B). After 
the hand was orientated in wrist neutral, the reference laser was switched off during the 
experimental procedure. The paper board set for each p rticipant was used across sessions to 
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Procedure for assessment of motor variability 
The experimental task involved repeated radial/ulnar deviation of the wrist between 
two target angle regions that were marked on the pap r board (Figure 2B). Participants were 
instructed to move the active laser as accurately as possible between two target regions: 80-
100% of their maximal radial deviation range to 20-40% of their maximal ulnar deviation 
range in time with a metronome (90 beats per minute) [6]. We used a metronome-based task 
as motor variability has been shown to change as a function of movement speed [3,9,18,21], 
thus ensuring any changes in motor variability could be attributed to pain and not to 
participants adjusting their movement speed across se ions. The targets were standardized to 
a percentage of maximal range to account for individual differences in maximal radial/ulnar 
deviation range of motion.  
 
At the start of each session, participants practised until they completed the task at the 
correct frequency. Data from the practice trial were not recorded. Emphasis was placed on 
moving to each target as accurately as possible. Forty-five repetitions were recorded starting 
and finishing in the neutral position before (Day -2 and Day 0 sessions), during (Day 2 and 
Day 4 sessions), and after a period of sustained elbow pain (Day 14 session). Participants 
were asked at the end of each 45-repetition trial whether they perceived fatigue in their 















Electromyography (EMG) was recorded from the right ECRB (electrode type and 
placement as described above). The ground electrode was placed over the right olecranon. 
The EMG signal was pre-amplified 1000 times, band pass filtered between 20 and 1000 Hz, 
and sampled at 2 kHz using Signal 3 software and Power 1401 data acquisition system 
(Cambridge Electronic Design, Cambridge, UK). 
 
Single-pulse, biphasic stimuli were delivered using a Magstim Super Rapid2 (Magstim 
Co. Ltd, Dyfed, UK) and a 7-cm figure of eight coil. The coil was positioned tangentially to 
the scalp with the handle pointing posteriorly at 45° from midline. This orientation is optimal 
for the induction of posterior-to-anterior (PA) directed current and activation of horizontal 
cortical connections in M1 [5,13]. The optimal scalp site (‘hotspot’) for evoking responses in 
the ECRB muscle was then established by systematically moving the coil in 1 cm increments 
around the motor cortex. The site that evoked the largest EMG responses at a given 
stimulator intensity was considered the hotspot. The stimulus intensity for mapping was set at 
120% of the resting motor threshold (rMT), defined as the minimum stimulator intensity at 
which 5 out of 10 stimuli applied at the hotspot evoked a response with a peak-to-peak 
amplitude of at least 50 µV [27]. This intensity was determined on Day -2 and kept constant 
on Days 0, 2, 4 and 14. 
 
Participants were fitted with a tight silicon cap marked with a 1 x 1 cm grid 
positioned and orientated to the vertex. The vertex was identified using the International 
10/20 system [42]. Five TMS pulses were applied, with an inter-stimulus interval of five 
seconds, at each site of the grid [15,93]. The number of scalp sites stimulated was 
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neuronavigation system (Brainsight2, Rogue Resolutions Ltd, Cardiff, UK) was used in 
conjunction with the silicon cap to ensure accurate coil placement at each grid site. 
Participants were instructed to maintain their right hand and forearm relaxed with their wrist 
pronated during the experiment. Trials that presented with background EMG activity were 
discarded (<3% of trials). All TMS procedures adhered to the TMS checklist for 
methodological quality [17]. 
 
Map volume, single site excitability, and centre of gravity (CoG) were calculated. 
Map volume was calculated as the sum of all active sit s. A site was considered ‘active’ 
when the mean peak-to-peak MEP amplitude of the five MEPs evoked at that site was greater 
than 50 µV. Single site excitability was calculated as the mean peak-to-peak MEP amplitude 
of the five MEPs delivered at the ‘hotspot’. The centr  of gravity was defined as the 
amplitude-weighted center of the map [90,92], and was calculated using  the following 
formula: CoG = ∑    ⁄ ∑  , ∑    ⁄ ∑  ; where: Vi = mean MEP amplitude at 
each site with the coordinates Xi , Yi. Test-retest r liability and validity of these procedures 
for calculating volume and centre of gravity for upper limb muscles has been previously 
demonstrated [49,58,90]. Specifically, studies have shown between session reliability for 
map volume and centre of gravity measures with a 24hour, 4-day, 1-week, or 2-week inter-
session interval [49,51,58,90]. 
 
Finally, the number of scalp sites over which TMS evoked a ‘discrete peak’ in activity 
in the corticomotor representation was determined. Using an established method, discrete 
peaks were identified if the average MEP amplitude at a grid site was greater than 50% of the 
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peak MEP amplitudes in 7 out of 8 surrounding grid sites, and were separated by at least 1 
grid site from another discrete peak [50,72,74,75]. 
 
Data analysis 
To determine whether subjects accurately moved the laser pointer to each target zone, 
video data of the laser was recorded during each trial and analyzed offline using MATLAB 
R2016b (Mathworks, Natick, MA, USA). Movement accuracy was expressed as a percentage 
and represented the proportion of repetitions within each experimental session in which 
participants successfully moved the laser to the radial and ulnar deviation target zones (see 
figure 3 for representative data). To analyse kinematic and EMG variability, events were 
created during the analyses of each 45-reptition trial o signify movement cycles – a 
movement cycle was defined as the period between th s arting angle of radial/ulnar 
deviation (wrist neutral) and when the hand passed through wrist neutral following 
movements to both radial and ulnar deviation targets). Kinematic variability was quantified 
as the mean standard deviation in both wrist flexion-extension and forearm pronation-
supination across each movement cycle in the 45-repetition trial. 
 
The EMG signals of ECRB were rectified, filtered (low-pass filtered at 25 Hz using a 
second-order Butterworth filter) and normalized to the peak EMG signal recorded for ECRB 
during a maximum voluntary contraction of handgrip (performed with participants seated 
upright with the elbow in approximately 90° degrees) in each experimental session. The 
mean standard deviation of the normalized root mean squared (RMS) values of ECRB across 
each movement cycle (defined above) in the 45-repetition trial were then used as a measure 
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kinematic and EMG variability was assessed at a whole-cycle level, but not with respect to 
sub-events within the cycle [29]. 
 
Statistical analysis 
Statistical Package for the Social Sciences (SPSS) software (version 23 IBM Corp, 
Armonk, NY, USA) was used for statistical analysis. All data were assessed for normality 
using visual inspection (Q-Q plot) and Shapiro-Wilk’s test. Paired sample t-tests were 
performed to compare learning effects and stability of corticomotor outcomes over two days 
in the absence of pain (Day -2 and Day 0). If normality was violated for the paired samples t-
test, a Wilcoxon signed-rank test was used. Intraclass correlation coefficients (ICC, two-way 
mixed effects) were performed to assess test re-test reliability of corticomotor (volume, 
discrete peaks, CoG) and motor adaptation (EMG and ki ematic variability) outcomes over 
the two baseline experimental sessions (Day -2 and Day 0). ICC values were interpreted as: 
poor (<0.50), moderate (0.50-0.65), good (0.65-0.80) or excellent (>0.80) [14,65]. 
Corticomotor outcomes (map volume, single site excitability, discrete peaks, CoG), 
movement accuracy, and EMG and kinematic variability data were compared between Days 
0, 2, 4, and 14 using a one-way repeated-measures analysis of variance (ANOVA). Data that 
did not meet assumptions of normality were log-transformed, and the Greenhouse-Geisser 
Correction was applied if data did not meet the assumption of sphericity. Where appropriate, 
post-hoc analyses were performed using Holm-Sidak multiple comparison tests. Pain (NRS 
scores), muscle soreness (Likert scale), and functio al limitation (PRTEE scores) were 
compared between Days 0, 2, 4, and 14 using the Friedman test, and if significant, post-hoc 
comparisons were performed using the Wilcoxon signed-rank test. Pearson correlations (or 
spearman correlations if data did not meet assumptions of normality) were used to assess the 
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kinematic variability in the presence of pain (Day 2 and Day 4) and after pain subsided (Day 
14). Statistical significance was set at P< 0.05. 
 
RESULTS 
Assessment of reliability of task performance and corticomotor outcomes in the absence of 
pain 
Motor variability and performance accuracy did not differ (EMG variability: t24 = -
1.5, p = 0.2; kinematic variability: t24 = -0.6, p = 0.5; performance accuracy: Z = -0.72, p = 
0.5) between the two pre-pain baseline sessions (Day -2 vs. Day 0). Similarly, corticomotor 
outcomes were stable when compared between Days -2 and 0, with discrete map peaks (Z = 
0.1, p = 0.9), volume (Z = 1.1, p = 0.3), and CoG (Latitude: Z = -1.7, p = 0.7; Longitude: Z = 
1.1, p = 0.3) not significantly changed over time (Table 1). Good to excellent test-retest 
reliability was demonstrated for all corticomotor (CoGx: ICC = 0.93, p<0.001; CoGy: ICC = 
0.67, p<0.001; MapVol: ICC = 0.86; p<0.001) and motor variability (Kinematic: ICC = 0.75, 
p<0.001; EMG: ICC = 0.86, p<0.001) outcomes between Days -2 and 0, with the exception 
of the discrete peak variable where test-retest reliability was poor (ICC = 0.46, p = 0.1). 
Consequently, the discrete peak variable was removed from further analysis. 
 
Pain, muscle soreness, and functional limitation  
Three individuals did not develop pain in response to NGF injection and were 
excluded from analyses. Repeated injection of NGF resulted in pain (Friedman: X2 (3) = 
67.1, p<0.001; Figure 4A), muscle soreness (Friedman: X2 (3) = 66.5, p<0.001; Figure 4B), 
and functional limitation (Friedman: X2 (3) = 66.6, p<0.001; Figure 4C). Post-hoc analysis 
demonstrated pain and muscle soreness that was present at Day 2 (pain: day 0 vs. 2: p<0.001; 
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soreness: day 0 vs. 4: p<0.001) and returned toward b seline at Day 14 (pain: day 0 vs. 14: p 
= 0.1; soreness: day 0 vs. 14: p = 0.1). Similarly, functional limitation was present at Day 2 
(day 0 vs. 2: p<0.001), persisted at Day 4 (day 0 vs. 4: p<0.001), and returned to baseline at 
Day 14 (day 0 vs. 14: p = 0.1). No participant reported fatigue during the experimental 
protocol.   
 
Influence of sustained muscle pain on motor variability 
Attainment of the goal in the radial and ulna deviation direction was not affected by 
sustained muscle pain, with the proportion of successful repetitions unchanged over time 
(ANOVA: F2.1, 51.5 = 0.8, p = 0.5; Day 0 = 99%, Day 2 = 99%, Day 4 = 96%, Day 14 = 99%). 
At the group level, EMG variability (ANOVA: F2.2, 54.4 = 7.1, p = 0.001; Figure 5A), but not 
kinematic variability (ANOVA: F2.3, 62 = 0.1, p = 0.9; Figure 5B), was altered in response to 
sustained muscle pain. EMG variability was reduced at Day 4 (post-hoc: day 0 vs. 4: p = 
0.04) and Day 14 (post-hoc: day 0 vs. 14: p = 0.01) relative to baseline, but was unchanged at 
Day 2 (post-hoc: day 0 vs. 2: p = 0.6). However, visual inspection of the data revealed clear 
variation in both EMG and kinematic variability betw en individuals, with some individuals 
displaying increased motor variability at Days 2 and 4 (Day 2, EMG: n=11; kinematic: n=11; 
Day 4, EMG: n=9; kinematic: n=13; Figure 5A and 5B;) while remaining subjects showed a 
decrease in variability on both days. Of the 11 individuals that displayed increased EMG and 
kinematic variability at Day 2, nine (82%) and seven (64%) also displayed an increase in 
variability at Day 4, respectively. Of the 14 indivi uals that displayed decreased EMG and 
kinematic variability at Day 2, nine (82%) and 12 (86%) also displayed a decrease in 
variability at Day 4 respectively, suggesting a high level of consistency in the motor strategy 
adopted by an individual over time. Further, across Days 2, 4, and 14, individuals that 
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versa) (r = 0.55, p = 0.004). Post-hoc comparison, using Pearson correlations, of pain (NRS 
scores), muscle soreness (Likert scale), and functio al limitation (PRTEE scores) between 
those who displayed increased vs. decreased EMG and kinematic variability at Days 2 and 4 
did not reveal any associations (all: p>0.12). 
 
Influence of sustained pain on corticomotor excitability and relationship to motor 
variability 
Relative to baseline, map volume was reduced at Day 2 (ANOVA: F2.1, 51 = 4.1, p = 
0.02; post-hoc: day 0 vs. 2: p = 0.02) and Day 4 (post-hoc: day 0 vs. 4: p = 0.003), and 
returned to baseline at Day 14 (post-hoc: day 0 vs. 14: p = 0.9; Figure 5C). Corticomotor 
excitability at the hotspot followed the same pattern (ANOVA: F2.2, 51 = 4.2, p = 0.01) with a 
reduction in excitability at Day 2 (post-hoc: day 0 vs. 2: p = 0.04) and Day 4 (post-hoc: day 0 
vs. 4: p = 0.004), returning to baseline at Day 14 (post-hoc: day 0 vs. 14: p = 0.7). There was 
no change in the map CoG over time (Latitude: ANOVA: F3, 72 = 0.5, p = 0.7; Longitude: 
ANOVA: F3, 72 = 0.6, p = 0.6). Individuals who displayed a reduction in map volume 
following four days of sustained pain also displayed a reduction in EMG variability, whereas 
individuals who increased map volume displayed increased EMG variability (r = 0.43, p = 
0.034; Figure 5D). Pain, muscle soreness, functional limitation, age and gender for the 
overall sample and for the individuals who increased and decreased EMG variability at Day 4 
are presented in Table 2. There was no relationship between map volume and EMG 
variability at Day 2 (rho = -0.16, p = 0.47) or Day 14 (r = -0.17, p = 0.43), nor between map 












This study provides insight into motor adaptation, a d the relationship between motor 
adaptation and corticomotor excitability, in response to progressively developing, sustained 
pain. At the group-level, EMG variability was decreas d four days after pain onset and 
persisted at Day 14 despite resolution of pain. No changes were observed in kinematic data at 
the group level. However, there was substantial inter-individual variability in motor 
adaptation, with 36% and 52% of individuals displaying increased EMG and kinematic 
variability respectively, following four days of pain. A novel finding was that individuals 
who displayed increased EMG variability also displayed increased map volume, whereas 
individuals who decreased EMG variability displayed decreased map volume. These findings 
suggest a relationship between motor adaptation in pai  and corticomotor excitability that is 
specific to the individual. 
 
Previous studies have investigated motor adaptation in acute[4,24,55,91] or chronic 
pain[44,48,94], but evidence in the transition to sustained pain is limited. One previous NGF 
study evaluated the direction and variation of force during an isometric wrist extension task. 
That study found altered force direction, but not frce variation, in radial-ulnar deviation 
following four days of pain[53]. The present study extends these findings by characterizing 
EMG and kinematic variability as pain persists over a similar time-frame. At the group level, 
we show reduced EMG variability, but no change in ki ematic variability, following four 
days of pain. However, it was clear on visual inspection of the data that individuals adopted 
different motor strategies in response to pain. Sixteen (64%) participants reduced EMG 
variability at Day 4, while nine (36%) increased variability. Similarly, 52% of individuals 
increased (n=13), and 48% decreased (n=12), kinematic variability, explaining the 
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The presence of inter-individual variability is consistent with the idea that motor 
adaptation to pain is not stereotypical, but specific to the individual[35,34] and with studies 
demonstrating individual-specific motor adaptation n acute experimental pain[33,70,78,87]. 
For example, when pain is induced in the back muscles via injection of hypertonic saline, 
62% of individuals increase movement variability and 38% reduce variability[70]. Similarly, 
the current data suggest that when pain is sustained for four days, although all participants 
maintained task performance, the motor strategies us d to achieve the task differed between 
individuals. Although both motor strategies (increas d or decreased variability) may be 
successful at protecting the painful part in the short-term[34], individuals who adopt less 
variable motor patterns may be at greater risk of chronic pain as a result of stereotypical 
movement patterns that increase tissue loading[28,34,48,55,79]. Indeed, reduced motor 
variability in individuals with low back pain is considered a risk factor for the maintenance 
and reoccurrence of pain[22,55]. Further research is required to understand the trajectory of 
recovery following an episode of pain in those indivi uals that respond with an increase or 
decrease in motor variability.   
 
Electromyography and kinematic variability failed to return to baseline at Day 14 in 
any subject despite resolution of pain. This was true egardless of whether individuals 
exhibited increased or decreased motor variability. This is in agreement with work 
demonstrating that changes in motor control with pain do not always resolve after pain has 
ceased[47,55,88]. For example, altered motor variability of postural strategies induced by 
acute experimental back pain persists after pain has resolved[55]. These findings support the 
notion that motor strategies adopted in the early stages of pain may not return to the original 
strategy following resolution of pain and could be a predisposing factor for the development 
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One mechanism thought to contribute to motor adaptation in pain is altered 
corticomotor excitability[74,83,86,85]. Studies have shown increased corticomotor 
excitability when pain is sustained for four days[19,72]. In contrast, the present study found a 
decrease in corticomotor excitability. This discrepancy could be explained if the cortical 
strategy adopted in response to pain is not uniform across individuals. A recent study using 
the NGF model revealed individual differences in corti motor excitability such that 60% of 
individuals displayed corticomotor depression and 40% displayed corticomotor 
facilitation[76]. Similar inter-individual variation was present in the current study with those 
who displayed reduced corticomotor excitability also displaying reduced motor variability 
and vice versa. This finding is consistent with motor learning studies that demonstrate a 
relationship between motor performance and corticomot r excitability[10-12]. These findings 
provide the first evidence of a link between corticomotor excitability and motor adaptation in 
response to pain that differs between individuals. 
 
Why individuals adopt different motor and cortical strategies is not known.  As pain 
intensity was not different between those who increased or decreased motor variability, these 
differences may relate to an individual’s beliefs and attitudes towards pain, as well as their 
perception of threat[33,55,70]. For instance, those who perceive experimentally-induced back 
pain to be more threatening respond with a greater reduction in motor variability than those 
who perceive less threat[55]. Similarly, individuals who display high pain catastrophising and 
kinesiophobia to experimentally-induced back pain also display low variability in motor 
control strategies during trunk flexion-extension movements, whereas those who display low 
catastrophising and kinesiophobia display high variability[70]. Thus, one possibility is that 
individuals who perceived movement at the wrist to be highly threatening may have exerted 
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corticomotor excitability), whereas those who perceived movement to be less threatening 
may have exerted less control over variability (leading to an increase in variability and 
corticomotor excitability).  
 
Alternatively, experimentally induced nociception may have interfered with 
proprioceptive signaling and contributed to motor adaptation[52,84]. However, we consider 
this hypothesis less likely as although animal studies emonstrate excitation of high threshold 
mechanosensitive group IV muscle nociceptors with NGF[38,37], human studies show no 
effect of NGF on vibration sense or the jaw stretch reflex[81] and data on joint position sense 
collected as part of this protocol (published elsewh re) were unchanged over time[80]. It is 
also plausible that regions outside the sensorimotor cortex contributed to motor adaptation. 
For example, the cerebellum plays a key role in synchronization tasks[8,20] and studies have 
demonstrated activation of the cerebellum during the perception of pain[56]. Further research 
is needed to investigate the influence of activity in other brain regions on motor adaptation in 
pain. 
 
The results of this study should be considered in light of several limitations. First, 
small training effects may have carried over between the pre-pain baseline sessions and the 
pain sessions. However, motor variability was stable across the two pain-free sessions 
suggesting that saturation in task variation occurred prior to NGF injection. Second, motor 
variability was assessed across the whole movement cycle using standard deviation, and other 
methods such as evaluating coordination variability between movement planes[31,64] or 
temporal structure of repetitive movements[66] were not included. Nonetheless, standard 
deviation is a valid measure of motor variability and has been widely used in pain 
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meaning it was not possible for participants to adopt an alternative speed-accuracy strategy. 
Given the relevance of the speed-accuracy trade-off to motor skill performance[40], future 
studies should consider an individual’s speed-accuracy strategy when investigating motor 
adaptation in pain. Fourth, single site excitability was calculated as the mean peak-to-peak 
MEP amplitude of five MEPs. While five MEPs have been shown to produce good between 
session reliability for calculating single site excitability [14], a higher number of stimuli 
(between 20-30) is required to optimise this assessm nt and produce excellent 
reliability[16,25]. Finally, re-learning of the task following a 10-day period with no task 
exposure may have contributed to the altered motor variability observed at Day 14. Previous 
literature has shown that motor skill performance degrades over time with extended delays in 
practice[23,71]. However, as a practice period was provided prior to each recorded trial, any 
influence of re-learning would likely have been mini al.  
 
This study raises considerations for future research. As we were primarily interested 
in motor adaption as pain developed and peaked at Day 4, data were not collected between 
Days 4 and 14 and it is unknown if pain and corticomotor excitability follow a similar 
recovery trajectory. Future work should include a greater number of test sessions in the late 
stage of the model and incorporate daily pain diaries to ensure high temporal resolution of 
outcomes. It is also important to note that single-pulse TMS provides a measure of 
excitability along the entire corticomotor pathway. It is not possible to determine whether 
changes in corticomotor excitability occurred at spinal or cortical level using the current data. 
Similarly, intracortical inhibitory and facilitatory mechanisms which are known to be altered 
following four days of NGF-induced pain[72], were not evaluated. Further examination of 
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engagement in musical or sporting activities could influence corticomotor excitability and 
motor adaptation in pain[63,89,41] and this information should be captured in future studies. 
 
Conclusions 
The motor strategy adopted in the transition to sustained pain is related to the motor 
cortical strategy, but the precise strategy differs between individuals. These findings are 
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Figure 1. Experimental protocol. Participants attended five experimental sessions (Days -2, 
0, 2, 4, and 14). At the beginning of each session, motor cortical maps were measured and 
motor variability assessed. On Days 0 and 2, injection of nerve growth factor (NGF) into the 
right ECRB muscle was performed immediately after completion of all outcome assessments. 
Pain intensity (NRS), muscle soreness (Likert scale), nd functional limitation (patient rated 
tennis elbow evaluation, PRTEE) were recorded on Days 0, 2, 4, and 14. 
 
Figure 2: Experimental set-up for radial/ulnar deviation task showing the position of the 
upper arm from the side view (A) and the view of board (B) positioned in front of each 
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Figure 3: Representative example of ECRB EMG and wrist angle kin matics across a 45-
repetition trial of the radial/ulnar deviation task. A. Radial/ulnar deviation angle (blue line) 
and ECRB EMG activity (red line). B. Forearm pronation/supination angle (orange line). C. 
Wrist flexion/extension angle (black line).    
 
Figure 4. Mean (± SE, N = 25) pain NRS scores (A), Likert scores of muscle soreness (B), 
and functional limitation assessed by PRTEE (C) at each time-point (Days 0, 2, 4, and 14). * 
P<0.05 relative to Day 0 is illustrated.  
 
Figure 5. Percent change in EMG (A) and kinematic (B) variability at Days 2, 4, and 14, 
normalised to baseline (Day 0). The black lines represent group data (mean ± SE; N = 25) 
and the grey lines individual data. Illustration of group mean (n=25, C) map volume obtained 
for the ECRB muscle at each time point (Days 0, 2, 4, and 14). Coordinates are referenced to 
the stimulation site that evoked the greatest motor ev ked potential (centre grid reference in 
map) obtained for each individual. Maps for Days 2, 4, and 14 are normalised to the 
maximum MEP on Days 0. The coloured scale represents the proportion of the maximum 
MEP amplitude of Day 0. D. Scatter plot (N=25, percent change from baseline) showing the 
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Table 1: Movement and corticomotor map measures (mean ± standard deviation) for Days -2 
and 0.  
 
Day -2 Day 0 
Kinematic variability (degree) 1.20 ± 0.45 1.25 ± 0.54 
EMG variability (mV) 0.011 ± 0.006 0.012 ± 0.007 
Performance accuracy (% accuracy) 96% 99% 
Discrete peaks (number) 1.88 ± 0.93 1.84 ± 0.69 
CoG latitude (cm) 5.79 ± 0.81 5.67 ± 0.75 
CoG longitude (cm) 1.10 ± 0.68 1.14 ± 0.65 
Map volume (mV) 8.04 ± 3.09 8.28 ± 2.58 










Copyright  8 8 by the International Association for the Study of Pain. Unauthorized reproduction of this article is prohibited.            2019
Table 2: Pain, muscle soreness, functional limitation, age nd gender (mean ± standard deviation) for the overall sample and for the individuals  
 
who increased and decreased EMG variability at Day 4. 
VAR, variability; EMG, electromyography; mV, millivolts; cm, centimetres 
 
Variables  Overall (n=25) Increase EMG VAR (n=9) Decrease EMG VAR (n=16) 
 Day 0 Day 2 Day 4 Day 14 Day 0 Day 2 Day 4 Day 14 Day 0 Day 2 Day 4 Day 14 
Pain - 3.2±2.1 3.1±1.9 0.3±0.7 - 3.3±1.8 3.1±0.9 0.2± 3 - 3.1±2.3 3.4±2.2 0.5±0.8 
Muscle soreness - 2.6±1.4 2.8±1.6 0.4±0.6 - 2.8±1.5 2.9±1.5 0.4±0.5 - 2.4±1.3 3.0±1.7 0.4±0.6 
Functional limitation - 9.8±6.7 11.8±8.2 0.9±2.4 - 9.9±6.2 11.5±5.9 0.3±0.3 - 9.7±7.5 11.6±5.2 0.5±0.6 
Age (years) 23.9 ± 4.0 25.1±5.1 23.4±2.3 
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